Total Number of Shares Sample Clauses
Total Number of Shares. Subject to this Option. The total number of shares of Common Stock subject to this option is [___].
Total Number of Shares. The total number of shares authorized to be issued by the Company shall be 80,000 (Eighty Thousand) shares.
Total Number of Shares. Subject to this Option. The total number of shares of Common Stock subject to this option is 120,000 Shares.
Total Number of Shares. The total number of Underlying Ordinary Shares issued pursuant to this Agreement over a 12-month rolling period represents, once issued and together with all the other Ordinary Shares which have been admitted to trading on the regulated market of Euronext over the same 12 month period on the basis of Article 1, paragraph 5.a) of the Prospectus Regulation, less than 20% of the total number of Ordinary Shares already admitted to trading on Euronext on the date the admission to trading of the Underlying Ordinary Shares is requested and no prospectus is required for such admission to trading in France. Any certificate signed by any officer or representative of the Company or any of its subsidiaries and delivered to the Agent or counsel for the Agent in connection with an issuance of Shares shall be deemed a representation and warranty by the Company to the Agent as to the matters covered thereby on the date of such certificate. The Company acknowledges that the Agent and, for purposes of the opinions to be delivered pursuant to Section 4(p) hereof, counsel to the Company and counsel to the Agent, will rely upon the accuracy and truthfulness of the foregoing representations and hereby consents to such reliance.
Total Number of Shares. The total number of shares of Common Stock that each Purchaser shall purchase as Purchased Shares at the Closing shall be equal to the quotient of the aggregate purchase price above hereto (as adjusted pursuant to clause (iii) below, such Purchaser's “Purchase Price”); provided, however, that (i) no fractional shares of Common Stock will be issued as Purchased Shares, (ii) any fractions shall be rounded down to the nearest whole number of Common Stock, and (iii) each Purchaser's Purchase Price will be reduced by the value of any such fractional share (as calculated on the basis of the Offer Price). The date and time of the Closings are referred to herein as the “Closing Date.”
Total Number of Shares. The total number of shares authorized to be issued by the Company shall be twenty thousand (20,000) shares.
Total Number of Shares. 14 ARTICLE III
Total Number of Shares. Average Price Paid Total Purchase
Total Number of Shares. Upon the Closing, the Company will have a total of 57,500,000 authorized shares, with 50,000,000 Ordinary Shares and 7,500,000 Preferred Shares respectively.
Total Number of Shares. See the Appendix Total Number of Open C-1 Units (to be converted into Shares upon the Conversion): See the Appendix Vesting Schedule: See the Appendix By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the Award Agreement and this C-1 Grant Notice. Participant has reviewed the Award Agreement, the Plan and this C-1 Grant Notice, has had an opportunity to obtain the advice of counsel and his or her tax and financial advisors prior to executing this C-1 Grant Notice and fully understands all provisions of the Award Agreement, the Plan and this C-1 Grant Notice. Participant hereby (i) agrees to accept as binding all decisions or interpretations of the Administrator upon any questions arising under the Plan, the Award Agreement or this C-1 Grant Notice, (ii) agrees and acknowledges that the rights and benefits under the Award Agreement and this C-1 Grant Notice are in full satisfaction of any rights or benefits under the Unit Agreement or with respect to the Open C-1 Units that shall terminate with no further force and effect as of the date of the Conversion, (iii) consents to the actions and treatment of the Open C-1 Units contemplated hereby, (iv) fully releases the Company and its Affiliates for any claims or liabilities, whether known or unknown, in respect of such Open C-1 Units and the Unit Agreement and (v) has either previously delivered an executed “lock-up” agreement in the form requested by the Company in connection with the Company’s IPO or is delivering such an executed agreement concurrently with the delivery of this C-1 Grant Notice. Ardent Health Partners, Inc. Participant By: By: Name: Name: Title: (Print Name) Capitalized terms used in this Annex 1 and, if applicable, the Appendix attached hereto, and not specifically defined herein or therein shall have the meanings specified in the Plan and the attached C-1 Grant Notice and Award, and for the avoidance of doubt, this Annex 1 and the Appendix attached hereto shall be included among the overall documentation that shall constitute the C-1 Grant Notice. The chart in the Appendix that is attached to this Annex 1 summarizes the Open C-1 Units that shall relate to the Shares granted to Participant pursuant to the Plan and the attached C-1 Grant Notice and Award Agreement, as well as the vesting schedule that shall apply to such Shares. An updated version of the Appendix will be delivered to Participant as soon as practicable following the consummation of the ...